Literature DB >> 33552670

Hemichorea-Hemiballismus as a Presentation of Cerebritis from Intracranial Toxoplasmosis and Tuberculosis.

Nico Paulo M Dimal1, Nigel Jeronimo C Santos2, Nikolai Gil D Reyes1, Mina N Astejada1, Roland Dominic G Jamora1.   

Abstract

Background: There is limited literature documenting hemichorea-hemiballism (HCHB) resulting from co-infection of toxoplasmosis and tuberculosis (TB) in acquired immunodeficiency syndrome (AIDS). Toxoplasmic abscess is the most common cause while TB is a rare etiology. Case Description: We describe a 24-year-old male with AIDS-related HCHB as the presentation of cerebritis on the right subthalamic nucleus and cerebral peduncle from intracranial toxoplasma and TB co-infection. Antimicrobials and symptomatic therapy were given. Marked improvement was seen on follow-up. Discussion: HCHB may be the initial presentation of intracranial involvement of this co-infection in the setting of AIDS and is potentially reversible with timely management. Highlights: Hemichorea-hemiballismus (HCHB) may be an initial presentation of intracranial involvement of concomitant toxoplasmosis and tuberculosis causing focal cerebritis in the contralateral subthalamic nucleus and cerebral peduncle, particularly in the setting of human immunodeficiency virus infection.Acquired immunodeficiency syndrome-related HCHB is potentially reversible with timely diagnosis and treatment. Copyright:
© 2021 The Author(s).

Entities:  

Keywords:  cerebritis; hemiballismus; hemichorea; intracranial tuberculosis; toxoplasmosis

Mesh:

Year:  2021        PMID: 33552670      PMCID: PMC7824977          DOI: 10.5334/tohm.576

Source DB:  PubMed          Journal:  Tremor Other Hyperkinet Mov (N Y)        ISSN: 2160-8288


  40 in total

1.  Hemichorea in tuberculous meningitis.

Authors:  Marcus Vinicius Pinto; Tiago Aguiar; Renata Nogueira; Ana Carolina Dias; Ana Lúcia Rosso
Journal:  Arq Neuropsiquiatr       Date:  2014-03       Impact factor: 1.420

2.  Movement disorders identified in patients with intracranial tuberculomas.

Authors:  F Alarcón; J C Maldonado; J W Rivera
Journal:  Neurologia       Date:  2011-02-22       Impact factor: 3.109

3.  Polymerase chain reaction for non-invasive diagnosis of brain mass lesions caused by Mycobacterium tuberculosis: report of five cases in human immunodeficiency virus-positive subjects.

Authors:  L Monno; G Angarano; C Romanelli; A Giannelli; A Appice; S Carbonara; D Costa; G Pastore
Journal:  Tuber Lung Dis       Date:  1996-06

4.  [Hemiballismus disclosing cerebral toxoplasmosis and acquired immunodeficiency syndrome].

Authors:  A Awada
Journal:  Rev Neurol (Paris)       Date:  1993       Impact factor: 2.607

5.  Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients.

Authors:  R B Dewey; J Jankovic
Journal:  Arch Neurol       Date:  1989-08

6.  Utility of PCR assay in diagnosis of en-plaque tuberculoma of the brain.

Authors:  K K Singh; M D Nair; K Radhakrishnan; J S Tyagi
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

7.  [Hemichorea associated with cerebral toxoplasmosis and AIDS].

Authors:  N S Garretto; J A Bueri; M Kremenchutzky; D Consalvo; M Segura; O Genovese
Journal:  Arq Neuropsiquiatr       Date:  1995-03       Impact factor: 1.420

8.  Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis.

Authors:  J R Sanchez-Ramos; S A Factor; W J Weiner; J Marquez
Journal:  Mov Disord       Date:  1989       Impact factor: 10.338

9.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

Review 10.  Central nervous system tuberculosis: an imaging-focused review of a reemerging disease.

Authors:  Morteza Sanei Taheri; Mohammad Ali Karimi; Hamidreza Haghighatkhah; Ramin Pourghorban; Mohammad Samadian; Hosein Delavar Kasmaei
Journal:  Radiol Res Pract       Date:  2015-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.